Skip to main content

Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies

Breast Cancer Research and Treatment volume 135, pages 647–654 (2012)Cite this article

Abstract

Several observational studies have investigated the role of body mass index (BMI) in second primary cancer incidence in women with breast cancer. We conducted a systematic review and meta-analysis of the evidence to assess the strength of this association. PubMed and Embase were searched for observational studies up to May 2012, and the reference lists of studies included in the analysis were examined. Random effects models were used to estimate summary relative risks (RRs) and 95 % confidence intervals (CIs). Thirteen prospective studies, five cohort and eight nested case–control studies, were included. In categorical meta-analyses of BMI, obesity was associated to significantly increased risks of contralateral breast (RR = 1.37, 95 % CI: 1.20–1.57), breast (RR = 1.40, 95 % CI: 1.24–1.58), endometrial (RR = 1.96, 95 % CI: 1.43–2.70), and colorectal (RR = 1.89, 95 % CI: 1.28–2.79) second primary cancers. For a BMI increase of 5 kg/m2, dose–response meta-analyses resulted in significantly increased RRs of 1.12 (95 % CI: 1.06–1.20) and 1.14 (95 % CI: 1.07–1.21) for contralateral breast and breast second primary cancers, respectively. The summary RR for endometrial second primary cancers was 1.46 (95 % CI: 1.17–1.83) for a 5-unit increment. This result emphasizes the importance of prevention policies aiming to reduce overweight and obesity prevalence. Clinical trials in breast cancer patients with excess body weight evaluating the effect of normal weight restoration on second primary cancer incidence are needed.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Ferlay J, Shin HR, Bray F et al. (2010) GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France. http://globocan.iarc.fr. Accessed May 31, 2011

  2. Curtis RE, Freedman DM, Ron E et al. (2006) New malignancies among cancer survivors: SEER Cancer Registries, 1973–2000. National Cancer Institute, NIH Publ. No. 05-5302, Bethesda, MD

  3. Mellemkjaer L, Friis S, Olsen JH et al (2006) Risk of second cancer among women with breast cancer. Int J Cancer 118:2285–2292

    PubMed  Article  CAS  Google Scholar 

  4. Brown LM, Chen BE, Pfeiffer RM et al (2007) Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat 106:439–451

    PubMed  Article  Google Scholar 

  5. World Cancer Research Fund and American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC

    Google Scholar 

  6. Reeves GK, Pirie K, Beral V et al (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134

    PubMed  Article  Google Scholar 

  7. Majed B, Moreau T, Senouci K et al (2008) Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111:329–342

    PubMed  Article  Google Scholar 

  8. Majed B, Dozol A, Ribassin-Majed L et al (2011) Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association. Breast Cancer Res Treat 126:729–738

    PubMed  Article  Google Scholar 

  9. Majed B, Ribassin-Majed L, Asselain B (2011) Overweight breast cancer survivors are at increased risk of contralateral breast cancers at the long term follow-up. Am J Epidemiol 173(suppl 11): S235

  10. Li CI, Daling JR, Tang MTC, Malone KE (2011) Relationship between diabetes and risk of second primary contralateral breast cancer. Breast Cancer Res Treat 125:545–551

    PubMed  Article  Google Scholar 

  11. Bernstein JL, Thompson WD, Risch N, Holford TR (1992) Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136:925–936

    PubMed  CAS  Google Scholar 

  12. Horn PL, Thompson WD (1988) Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol 128:309–323

    PubMed  CAS  Google Scholar 

  13. Dignam JJ, Wieand K, Johnson KA et al (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467–1476

    PubMed  Article  CAS  Google Scholar 

  14. Li CI, Malone KE, Porter PL, Daling JR (2003) Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer 89:513–518

    PubMed  Article  CAS  Google Scholar 

  15. Dignam JJ, Wieand K, Johnson KA et al (2006) Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat 97:245–254

    PubMed  Article  Google Scholar 

  16. Majed B, Moreau T, Senouci K et al (2009) Stoutness and prognosis of female non-metastatic breast cancer: results from a French observational cohort study. Bull Cancer 96:531–541

    PubMed  CAS  Google Scholar 

  17. Storm HH, Andersson M, Boice JD Jr et al (1992) Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst 84:1245–1250

    PubMed  Article  CAS  Google Scholar 

  18. Cook LS, White E, Schwartz SM et al (1996) A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control 7:382–390

    PubMed  Article  CAS  Google Scholar 

  19. Li CI, Daling JR, Porter PL et al (2009) Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. J Clin Oncol 27:5312–5318

    PubMed  Article  Google Scholar 

  20. Brooks JD, John EM, Mellemkjaer L et al (2012) Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Res Treat 131:571–580

    PubMed  Article  Google Scholar 

  21. Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM (2007) Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat 105:195–207

    PubMed  Article  Google Scholar 

  22. Ewertz M, Machado SG, Boice JD Jr, Jensen OM (1984) Endometrial cancer following treatment for breast cancer: a case–control study in Denmark. Br J Cancer 50:687–692

    PubMed  Article  CAS  Google Scholar 

  23. Pukkala E, Kyyrönen P, Sankila R, Holli K (2002) Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case–control study. Int J Cancer 100:337–341

    PubMed  Article  CAS  Google Scholar 

  24. Kmet LM, Cook LS, Weiss NS et al (2003) Risk factors for colorectal cancer following breast cancer. Breast Cancer Res Treat 79:143–147

    PubMed  Article  CAS  Google Scholar 

  25. Sánchez L, Lana A, Hidalgo A et al (2008) Risk factors for second primary tumours in breast cancer survivors. Eur J Cancer Prev 17:406–413

    PubMed  Article  Google Scholar 

  26. Greenland S, Longnecker M (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135:1301–1309

    PubMed  CAS  Google Scholar 

  27. Bekkering GE, Harris RJ, Thomas S et al (2008) How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol 167:1017–1026

    PubMed  Article  Google Scholar 

  28. Krueger H, McLean D, Williams D (2008) The prevention of second primary cancers. Prog Exp Tumor Res Basel Karger 40: I–VIII

  29. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    PubMed  Article  CAS  Google Scholar 

  30. Begg CB, Davey SG, Schneider M, Minder C (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

    PubMed  Article  CAS  Google Scholar 

  31. Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578

    PubMed  Article  Google Scholar 

  32. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591

    PubMed  Article  CAS  Google Scholar 

  33. Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316

    PubMed  Article  CAS  Google Scholar 

  34. Goodwin PJ, Esplen MJ, Winocur J (1995) Development of a weight management program in women with newly diagnosed locoregional breast cancer. In: Bitzer J, Stauber M (eds) Psychosomatic obstetrics and gynecology. Monduzzi Editore, International Proceedings Division, Bologna, pp 491–496

    Google Scholar 

  35. Ryu SY, Kim CB, Nam CM et al (2001) Is body mass index the prognostic factor in breast cancer? A meta-analysis. J Korean Med Sci 16:610–614

    PubMed  CAS  Google Scholar 

  36. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627–635

    PubMed  Article  Google Scholar 

  37. Chlebowski RT, Weiner JM, Reynolds R et al (1986) Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7:23–30

    PubMed  Article  CAS  Google Scholar 

  38. Camoriano JK, Loprinzi CL, Ingle JN et al (1990) Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8:1327–1334

    PubMed  CAS  Google Scholar 

  39. Bonomi P, Bunting N, Fishman D et al (1984) Weight gain during adjuvant chemotherapy or hormone-chemotherapy for stage II breast cancer evaluated in relation to disease free survival (DFS). Breast Cancer Res Treat 4:339

    Google Scholar 

  40. McTiernan A, Irwin M, VonGruenigen V (2010) Weight, physical activity, diet, and prognosis in breast and gynaecologic cancers. J Clin Oncol 28:4074–4080

    PubMed  Article  Google Scholar 

  41. Holmes MD, Chen WY, Feskanich D et al (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486

    PubMed  Article  CAS  Google Scholar 

  42. Abrahamson PE, Gammon MD, Lund MJ et al (2006) Recreational physical activity and survival among young women with breast cancer. Cancer 107:1777–1785

    PubMed  Article  Google Scholar 

  43. Pierce JP, Stefanick ML, Flatt SW et al (2007) Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25:2345–2351

    PubMed  Article  Google Scholar 

  44. Holick CN, Newcomb PA, Trentham-Dietz A et al (2008) Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17:379–386

    PubMed  Article  Google Scholar 

  45. Irwin M, Smith AW, McTiernan A et al (2008) Association of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol 26:3958–3964

    PubMed  Article  Google Scholar 

  46. Sternfeld B, Weltzien E, Quesenberry CP Jr et al (2009) Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev 18:87–95

    PubMed  Article  Google Scholar 

  47. Ibrahim EM, Al-Homaidh A (2011) Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol 28:753–765

    PubMed  Article  Google Scholar 

  48. Rock CL, Doyle C, Demark-Wahnefried W et al (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. doi:10.3322/caac.21142. [Epub ahead of print]

  49. Chlebowski RT, Blackburn GL, Thomson CA et al (2006) Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst 98:1767–1776

    PubMed  Article  Google Scholar 

  50. Pierce JP, Natarajan L, Caan BJ et al (2007) Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women’s Healthy Eating and Living (WHEL) randomized trial. JAMA 298:289–298

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank the following authors for sharing complementary data and information: Franco Berrino and Patrizia Pasanisi, Department of Preventive and Predictive Medicine, Istituto Nazionale Tumori, Milan, Italy; Linda S Cook, Department of Internal Medicine, University of New Mexico, Albuquerque, USA; Jim Dignam, Department of Health Studies, University of Chicago, USA; Marianne Ewertz, Department of Oncology, University of Southern Denmark, Odense, Denmark; Pentti Kyyrönen and Eero Pukkala, Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland; Christopher I Li, Divisions of Public Health Sciences and Human Biology, Fred Hutchinson Cancer Research Center, Seattle, USA; Maria Luisa López González, Department of Medicine, University of Oviedo, Oviedo, Spain; Bilal Majed, Biostatistics Department, Curie Institute, Paris, France; Hans H Storm and Maria Blettner, Danish Cancer Registry, Institute of Cancer Epidemiology, Copenhagen, Denmark. This work was supported by a grant from the French National Cancer Institute. Norat T and Chan DSM are supported by the World Cancer Research Fund (Continuous Update Project grant number 2007/SP01).

Conflict of interest

None.

Author information

Affiliations

  1. INRA, UMR1125 Unité de Recherche en Epidémiologie Nutritionnelle, 93017, Bobigny, France

    Nathalie Druesne-Pecollo, Mathilde Touvier, Emilie Barrandon, Laurent Zelek, Serge Hercberg & Paule Latino-Martel

  2. Inserm, UMR557 Unité de Recherche en Epidémiologie Nutritionnelle, 93017, Bobigny, France

    Nathalie Druesne-Pecollo, Mathilde Touvier, Emilie Barrandon, Laurent Zelek, Serge Hercberg & Paule Latino-Martel

  3. CNAM, Unité de Recherche en Epidémiologie Nutritionnelle, 93017, Bobigny, France

    Nathalie Druesne-Pecollo, Mathilde Touvier, Emilie Barrandon, Laurent Zelek, Serge Hercberg & Paule Latino-Martel

  4. Université Paris 13, Sorbonne Paris Cité, Unité de Recherche en Epidémiologie Nutritionnelle, 93017, Bobigny, France

    Nathalie Druesne-Pecollo, Mathilde Touvier, Emilie Barrandon, Laurent Zelek, Serge Hercberg & Paule Latino-Martel

  5. Department of Epidemiology and Public Health, Imperial College, London, UK

    Doris S. M. Chan & Teresa Norat

  6. Department of Medical Oncology, Avicenne Hospital, Bobigny, France

    Laurent Zelek

  7. Department of Public Health, Avicenne Hospital, Bobigny, France

    Serge Hercberg

  8. INRA, Bâtiment 400, 78352, Jouy-en-Josas cedex, France

    Nathalie Druesne-Pecollo

Authors
  1. Nathalie Druesne-Pecollo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mathilde Touvier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emilie Barrandon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Doris S. M. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Teresa Norat
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laurent Zelek
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Serge Hercberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Paule Latino-Martel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nathalie Druesne-Pecollo.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Druesne-Pecollo, N., Touvier, M., Barrandon, E. et al. Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat 135, 647–654 (2012). https://doi.org/10.1007/s10549-012-2187-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-012-2187-1

Keywords

  • Body mass index
  • Breast cancer
  • Meta-analysis
  • Second primary cancer prevention